CareDx, Inc.

As of June 30, 2026, CareDx, Inc. carries a market capitalization of 1.29B, placing it among publicly traded companies globally. Its enterprise value stands at 976.87M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

CareDx, Inc.'s next confirmed earnings release is scheduled for October 29, 2026.

As of June 30, 2026, CareDx, Inc. has 51.48M shares outstanding.

As of June 30, 2026, CareDx, Inc. trades at a trailing price-to-earnings ratio of 13.27. The price-to-sales ratio is 3.21, and the price-to-book ratio stands at 3.45.

As of June 30, 2026, CareDx, Inc. trades at an EV/EBITDA multiple of 8.72 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 2.44 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 10.32 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. CareDx, Inc. trades at an EV/FCF ratio of 12.42, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 976.87M versus a market cap of 1.29B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, CareDx, Inc. maintains a current ratio of 4.58, meaning it holds 4.6x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended June 30, 2026, CareDx, Inc. posted a return on equity (ROE) of 29.49, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 26.01 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 22.72, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 27.71, useful for judging operating efficiency across full business cycles. The company generates approximately 544,604.82 in revenue per employee across its workforce of 736.25, a quick read on workforce productivity versus industry peers. Inventory turnover of 7.72 indicates how many times CareDx, Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, CareDx, Inc. recorded 3.66M in income tax expense. That works out to an effective tax rate of 3.63, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 100.83M, leaving 97.17M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, CareDx, Inc.'s stock has gained approximately 391.28% over the past 52 weeks. The 50-day moving average sits at 49.85, while the 200-day moving average is 28.08.

Over the twelve months ended June 30, 2026, CareDx, Inc. generated 400.97M in revenue and converted that into 97.17M in net income, yielding earnings per share of 1.84. EBITDA reached 111.97M, while operating income came in at -3.70M.

As of June 30, 2026, CareDx, Inc. holds 327.04M in cash and equivalents against 16.85M in total debt, resulting in a net debt position of -327.04M. Total book value stands at 372.53M, with working capital of 293.69M providing operational flexibility.

CareDx, Inc. produced 81.98M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -3.34M in capital expenditures, free cash flow totaled 78.64M - equivalent to 1.53 per share.

Over the twelve months ended June 30, 2026, CareDx, Inc. posted a gross margin of 70.58, reflecting its pricing power and cost economics. The operating margin of -0.92 and net profit margin of 24.23 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield stands at 5.95, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 3.90, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to CareDx, Inc. shareholders.

As of June 30, 2026, CareDx, Inc. has an Altman Z-Score of 8.51, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.